--Trial to be used in support of NDA submission-- MOUNTAIN VIEW, Calif., Feb. 16 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. (NASDAQ:MAPP) today announced that the Company initiated a...
MOUNTAIN VIEW, Calif., Jan. 6 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. (NASDAQ:MAPP) today announced that the company will present at the 28th Annual J.P. Morgan Healthcare Conference...
MOUNTAIN VIEW, Calif., Nov. 12 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. (NASDAQ:MAPP) today announced that it has secured a committed equity financing facility under which it may sell...
MOUNTAIN VIEW, Calif., Nov. 11 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. (NASDAQ:MAPP) today announced that the company will present at the Lazard Capital Markets 6th Annual Healthcare...
MOUNTAIN VIEW, Calif., Oct. 29 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. (NASDAQ:MAPP) today announced that it has completed a planned interim safety review of the open-label...
-- Analysis Shows Potential of LEVADEX to Treat a Broad Spectrum of Migraine -- -- Company to Host Webcast on Monday, September 14th at 7:15 a.m. ET -- MOUNTAIN VIEW, Calif., Sept. 10...
- Investor Webcast to Discuss Phase 3 LEVADEX(TM) Data Presented in Late-Breaking Session at the 14th Congress of the International Headache Society - MOUNTAIN VIEW, Calif., Sept. 2...
- Company to Suspend Development of UDB - MOUNTAIN VIEW, Calif., July 9 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. (NASDAQ:MAPP) today announced that it has received a notice of...
MOUNTAIN VIEW, Calif., Oct. 5 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. announced today that it has priced its initial public offering of 5,000,000 shares of common stock at a price of...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.2294 | 0.981667551052 | 23.3684 | 23.6452 | 23.3684 | 10 | 23.44441346 | SP |
4 | 0.4178 | 1.80241587575 | 23.18 | 23.6452 | 22.4037 | 38 | 22.8587719 | SP |
12 | 0.964 | 4.25911689597 | 22.6338 | 23.6452 | 21.43 | 541 | 22.58735122 | SP |
26 | 1.8703 | 8.60798527212 | 21.7275 | 23.6452 | 21.118 | 299 | 22.51662304 | SP |
52 | 4.1878 | 21.5754765585 | 19.41 | 23.6452 | 18.9015 | 210 | 21.95343872 | SP |
156 | 3.4578 | 17.1688182721 | 20.14 | 23.6452 | 18.9015 | 804 | 20.6098165 | SP |
260 | 3.4578 | 17.1688182721 | 20.14 | 23.6452 | 18.9015 | 804 | 20.6098165 | SP |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約